- JP-listed companies
- Kitazato Corporation
- Financials
- Gross margin (%)
Kitazato Corporation (368A)
Market cap
¥48B
P/E ratio
12.1x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
| Period End | Gross margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2026 | 65.9 | -2.65% |
| Mar 31, 2025 | 67.7 | -3.07% |
| Mar 31, 2024 | 69.8 | -2.51% |
| Mar 31, 2023 | 71.6 |